Retrieve available abstracts of 57 articles: HTML format
Single Articles
May 2025
DUSKA LR, Lim J, Calderon Boyle TA, Guinter M, et al The BEV1L study: Do real-world outcomes associated with the addition of
bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce
clinical trial findings?
Cancer. 2025;131:e35821. PubMedAbstract available
SCHNEIDER DT, Witowski A, Abele M, Benesch M, et al Testicular and ovarian Juvenile granulosa cell tumors in children and
adolescents: Analysis of 113 patients registered to the German Registry for Rare
Pediatric Tumors (STEP).
Cancer. 2025;131:e35861. PubMedAbstract available
HARRIS AK, Nelson AT, Watson D, Mallinger PHR, et al Ovarian juvenile granulosa cell tumor: A report from the International Ovarian
and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1
Registries.
Cancer. 2025;131:e35862. PubMedAbstract available
EBOTT J, Grant KR, Farley J, Stasenko M, et al Gender equity gap persists, addressing the root cause through the lens of
gynecologic oncology: An evidenced-based review.
Cancer. 2025;131:e35843. PubMedAbstract available
HUANG CC, Ayala-Peacock DN, Stephens SJ, Chino JP, et al Recent advances in gynecologic radiation oncology.
Cancer. 2025;131:e35888. PubMedAbstract available
April 2025
KUNOS CA, Chauhan A Prospects for radioimmunotherapy panaceas in gynecologic oncology.
Cancer. 2025;131:e35841. PubMed
FREY MK, Liu JF Shedding LIGHT on the changing landscape of poly-ADP ribose polymerase inhibitors
in ovarian cancer.
Cancer. 2025;131:e35800. PubMed
APPLEBAUM JC, Ginsburg ES Parenthood after cancer: The critical, yet complex, contribution of gestational
carriers.
Cancer. 2025;131:e35853. PubMed
ELLINGTON TD, Wardell AC, Deal AM, Mersereau J, et al In vitro fertilization with cryopreserved oocytes or embryos after cancer: The
role of gestational carriers.
Cancer. 2025;131:e35844. PubMedAbstract available
March 2025
RAYCHAUDHURI S, McLaughlin E, Pennell ML, Stefanick M, et al The relationship between cardiometabolic abnormalities and mortality in the
Women's Health Initiative: A comparison of associations among women with cancer
to women without cancer.
Cancer. 2025;131:e35804. PubMedAbstract available
KARPEL HC, Zambrano Guevara LM, Rimel BJ, Hacker KE, et al The missing data: A review of gender and sex disparities in research.
Cancer. 2025;131:e35769. PubMedAbstract available
SOROURI K, Glass K, Ruddy KJ, Warner E, et al Anti-Mullerian hormone for assessing ovarian toxicity of cancer treatment in
young women: It's complicated.
Cancer. 2025;131:e35774. PubMed
BAE HS, Temkin SM Cervical cancer stigma - A silent barrier to the elimination of cervical cancer.
Cancer. 2025;131:e35776. PubMed
NIERENGARTEN MB More evidence on benefits of HIPEC for recurrent ovarian cancer.
Cancer. 2025;131:e35754. PubMed
February 2025
PENNINX BMF, Samson MJ, Schnog JB Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III-IVa
cervical cancer: is the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial practice changing?
Cancer. 2025;131:e35749. PubMedAbstract available
DUSKA LR, Petroni GR, Thaker PH, Crane EK, et al Update on safety and feasibility of the combination of pembrolizumab and pelvic
chemoradiation in locally advanced cervical cancer.
Cancer. 2025;131:e35757. PubMedAbstract available
NIERENGARTEN MB New standard of care for patients with locally advanced cervical cancer.
Cancer. 2025;131:e35739. PubMed
BAEKER BISPO J, Jemal A, Islami F Association of mental health treatment receipt with cancer screening among US
adults with a history of anxiety or depression.
Cancer. 2025;131:e35724. PubMedAbstract available
HIPPALGAONKAR N, Huo D, Hoskins KF The long road to unbiased estimates of pancreatic cancer incidence in the
hereditary breast and ovarian cancer syndrome.
Cancer. 2025;131:e35722. PubMed
NERO C, Trozzi R, Persiani F, Rossi S, et al POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a
large prospective single-center cohort.
Cancer. 2025;131:e35731. PubMedAbstract available
TEMKIN SM Chronic conditions, cancer disparities, and the unique needs of Black women with
ovarian cancer.
Cancer. 2025;131:e35735. PubMed
January 2025
REN W, Guo X, Liu Z, Wu Y, et al Burden of female-specific cancers in China from 1990 to 2021: A systematic
analysis for the Global Burden of Disease Study 2021.
Cancer. 2025;131:e35712. PubMedAbstract available
LIU YL, Mathews CA, Simpkins F, Cadoo KA, et al Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA
mutation and homologous recombination deficiency: Phase 2 LIGHT study final
overall survival analysis.
Cancer. 2025;131:e35707. PubMedAbstract available
NIERENGARTEN MB Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients
with high-risk locally advanced cervical cancer.
Cancer. 2025;131:e35688. PubMed
MAHALINGAM D, Owonikoko TK, Delpassand E, Mulcahy MF, et al A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of
advanced ovarian and other cancers.
Cancer. 2025;131:e35680. PubMedAbstract available
RICHARDS AR, Johnson CE, Montalvo NR, Alberg AJ, et al Comorbid conditions and survival among Black women with ovarian cancer.
Cancer. 2025;131:e35694. PubMedAbstract available
PANDEY AS, Drogan C, Huo D, Postula K, et al Anticipation in families with MLH1-associated Lynch syndrome.
Cancer. 2025;131:e35589. PubMedAbstract available
December 2024
HENDRIX EL, Chollette VY, Wentzensen N, Loukissas JK, et al Federal Cervical Cancer Collaborative: Improving cervical cancer prevention
through vaccination, screening, and management in safety-net settings of care.
Cancer. 2024 Dec 11. doi: 10.1002/cncr.35655. PubMedAbstract available
November 2024
NIERENGARTEN MB Common strategy to diagnose endometrial cancer may not be reliable for Black
women.
Cancer. 2024;130:3783. PubMed
NIERENGARTEN MB Women with more severe forms of endometriosis have a nearly 10-fold higher risk
of ovarian cancer.
Cancer. 2024;130:3784. PubMed
October 2024
KONDO T, Matsuki E, Takaku T, Watanabe N, et al Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of
tyrosine kinase inhibitors.
Cancer. 2024 Oct 30. doi: 10.1002/cncr.35611. PubMedAbstract available
JOHNSON HM, Song J, Warneke CL, Martinez AL, et al Outcomes of patients treated with chemotherapy for breast cancer during pregnancy
compared with nonpregnant breast cancer patients treated with systemic therapy.
Cancer. 2024 Oct 29. doi: 10.1002/cncr.35619. PubMedAbstract available
WILSON EM, Huang R, Jones KD, Hagemann IS, et al Challenges in implementation of molecular classification in early stage
endometrial cancer-An NRG Oncology cooperative group mixed-methods study.
Cancer. 2024 Oct 17. doi: 10.1002/cncr.35596. PubMedAbstract available
NIERENGARTEN MB Excellent outcomes with radiation alone for localized recurrences of endometrial
cancer.
Cancer. 2024;130:3400. PubMed
September 2024
MEGHANI K, Grover S Reply to "Assessing the impact of HIV status on cervical cancer treatment
outcomes in Botswana: A commentary".
Cancer. 2024 Sep 10. doi: 10.1002/cncr.35553. PubMed
JEYARAJ G Assessing the impact of HIV status on cervical cancer treatment outcomes in
Botswana: A commentary.
Cancer. 2024 Sep 10. doi: 10.1002/cncr.35545. PubMed
August 2024
SULLIVAN MW, Graves S, Adkoli A, Zhou Q, et al Factors associated with an inconclusive result from commercial homologous
recombination deficiency testing in ovarian cancer.
Cancer. 2024 Aug 16. doi: 10.1002/cncr.35523. PubMedAbstract available
ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al Association between racial residential segregation and screening uptake for
colorectal and cervical cancer among Black and White patients in five US health
care systems.
Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514. PubMedAbstract available
July 2024
PEREZ L, Dioun S, Primiano M, Blank SV, et al Considering screening for hereditary cancer syndromes at the time of obstetrical
prenatal carrier screening.
Cancer. 2024 Jul 22. doi: 10.1002/cncr.35480. PubMed
MACKAY H, Fernandes I Cell-free DNA in recurrent and metastatic endometrial cancer: The future is now?
Promises and potential pitfalls.
Cancer. 2024 Jul 10. doi: 10.1002/cncr.35448. PubMed
ELGHAZALY H, Azim HA, Rugo HS, Cameron D, et al Tailoring neo/adjuvant systemic therapy in breast cancer: "The advent of a
personalized approach"-The Breast-Gynecological and Immuno-Oncology International
Cancer Conference (BGICC) consensus and recommendations.
Cancer. 2024 Jul 10. doi: 10.1002/cncr.35389. PubMedAbstract available
BANERJEE S, Hasson SP Top advances of the year: Immunotherapy in endometrial cancer.
Cancer. 2024 Jul 4. doi: 10.1002/cncr.35417. PubMedAbstract available
NIERENGARTEN MB Significant overall survival benefit with dostarlimab plus chemotherapy in
advanced endometrial cancer.
Cancer. 2024;130:2245. PubMed
NIERENGARTEN MB Favorable overall survival trend with pembrolizumab plus chemotherapy for
endometrial cancer.
Cancer. 2024;130:2246. PubMed
June 2024
BEAVIS AL, Wethington SL, Yu R, Topel KM, et al Differential utilization of the online patient portal for completion of
health-related social needs screening during routine gynecologic cancer care.
Cancer. 2024 Jun 29. doi: 10.1002/cncr.35376. PubMedAbstract available
Erratum to "Role of surgical outcome as prognostic factor in advanced epithelial
ovarian cancer: A combined exploratory analysis of 3 prospectively randomized
phase 3 multicenter trials".
Cancer. 2024 Jun 7. doi: 10.1002/cncr.35344. PubMed
BLANC-DURAND F, Camilleri GM, Bayle A, Aldea M, et al Clinical utility of comprehensive liquid molecular profiling in patients with
advanced endometrial cancer.
Cancer. 2024 Jun 2. doi: 10.1002/cncr.35381. PubMedAbstract available
May 2024
LOGGERS ET, Chugh R, Federman N, Hartner L, et al Onset and resolution of ovarian toxicity with nirogacestat treatment in females
with desmoid tumors: Updated safety analyses from the DeFi phase 3 study.
Cancer. 2024 May 4. doi: 10.1002/cncr.35324. PubMedAbstract available
April 2024
DUSKA LR, Podwika SE, Randall LM Top advances of the year: Cervical cancer.
Cancer. 2024 Apr 23. doi: 10.1002/cncr.35334. PubMedAbstract available
STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al National organized screening programs for breast, colorectal, and cervical cancer
reduce socioeconomic disparities, but it is not enough.
Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335. PubMed
RUAN Y, Heer E, Brenner DR Reply to "National organized screening programs for breast, colorectal, and
cervical cancer reduce socioeconomic disparities, but it is not enough".
Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339. PubMed
NIERENGARTEN MB Promising new treatment approaches for locally advanced cervical cancer.
Cancer. 2024;130:1192. PubMed
ERICKSON BK, Slomovitz B, Powell M, Eskander RN, et al Top advances of the year: Uterine cancer.
Cancer. 2024 Apr 15. doi: 10.1002/cncr.35321. PubMedAbstract available
March 2024
MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al Significance of HIV status in cervical cancer patients receiving curative
chemoradiation therapy, definitive radiation alone, or palliative radiation in
Botswana.
Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289. PubMedAbstract available
LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al Factors contributing to differences in cervical cancer screening in rural and
urban community health centers.
Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265. PubMedAbstract available
MICHEL AD, Fontenot HB, Fuzzell L, Brownstein NC, et al Attitudes toward the American Cancer Society's 2020 cervical cancer screening
guidelines: A qualitative study of a national sample of US clinicians.
Cancer. 2024 Mar 4. doi: 10.1002/cncr.35269. PubMedAbstract available
February 2024
LIU YL, Weigelt B A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch
repair-deficient and microsatellite instability-high endometrial cancers.
Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267. PubMedAbstract available